Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells

Sandra Redlich1, Sandra Ribes, Sandra Schütze

  • 1Institute of Neuropathology, University Medical Center, Göttingen, Germany. s.redlich77@web.de

Abstract

Insights

Stimulating microglial cells with Toll-Like receptor (TLR) agonists enhances the brain's ability to fight Cryptococcus neoformans infections. This boosts phagocytosis and intracellular killing, offering potential therapeutic strategies for cryptococcal meningitis.

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Microbiology

Background:

  • Toll-Like receptors (TLRs) are pattern-recognition receptors crucial for identifying pathogen-associated molecular patterns (PAMPs).
  • Cryptococcal meningitis is a severe central nervous system (CNS) infection with high mortality and potential for lasting neurological damage.

Purpose of the Study:

  • To investigate the effect of TLR agonist stimulation on microglial cell phagocytosis of Cryptococcus neoformans.
  • To determine if TLR activation enhances the innate immune response against fungal CNS infections.

Main Methods:

  • Murine microglial cells were stimulated with agonists for TLR1/2, TLR3, TLR4, and TLR9.
  • Phagocytosis of encapsulated Cryptococcus neoformans by microglial cells was assessed.
  • Cytokine and chemokine release (TNF-α, CXCL1, IL-6, IL-10, MIP-2) was measured to indicate microglial activation.
  • MyD88-deficient cells were used to confirm the role of MyD88-dependent TLR signaling.

Main Results:

  • TLR agonist stimulation significantly increased the phagocytosis of Cryptococcus neoformans by microglial cells.
  • Stimulated cells exhibited enhanced intracellular killing of the fungus.
  • Activation of microglial cells was confirmed by increased release of pro-inflammatory mediators.
  • MyD88-deficient cells showed impaired phagocytic capacity compared to wild-type cells.

Conclusions:

  • Microglial cell stimulation via TLR agonists enhances the brain's defense against Cryptococcus neoformans.
  • This approach may be beneficial for immunocompromised patients struggling to clear fungal infections despite antifungal treatment.
  • Targeting TLRs could represent a novel therapeutic strategy for CNS fungal infections.